# A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

> **NCT06808477** · PHASE1 · RECRUITING · sponsor: **Bambusa Therapeutics** · enrollment: 198 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** BBT001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06808477
- **Lead sponsor:** Bambusa Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-27
- **Primary completion:** 2026-08-21
- **Final completion:** 2027-02-06
- **Target enrollment:** 198 (ESTIMATED)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06808477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06808477, "A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06808477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*